A Study Comparing the Effectiveness and Convenience of Dietary Therapy for Irritable Bowel Syndrome (IBS)
Launched by SHEFFIELD TEACHING HOSPITALS NHS FOUNDATION TRUST · Aug 27, 2019
Trial Information
Current as of April 24, 2025
Completed
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1. Irritable Bowel syndrome - as defined by abdominal pain and altered bowel habit in the absence of organic pathology to explain the symptoms.This is the contemporary definition as provided by the Rome IV committee.
- • 2. Age 18-65 years
- • 3. English literate
- • 4. Can travel to hospital
- • 5. Telephone/internet access
- Exclusion Criteria:
- • 1. Inflammatory bowel disease
- • 2. Coeliac disease
- • 3. Gastrointestinal cancer
- • 4. Previous abdominal surgery
- • 5. Scleroderma
- • 6. Poorly controlled diabetes
- • 7. Severe liver disease
- • 8. Severe renal disease
- • 9. Severe respiratory disease
- • 10. Severe cardiac disease
- • 11. Severe psychiatric disease
- • 12. Memory disorders
- • 13. Pregnant
- • 14. Current dietary interventions
- • 15. Recent/current use of Probiotics
- • 16. Recent/current use of Antibiotics
- • 17. Recent/current use of Narcotics
- • 18. Currently titrated antidepressants (i.e. not on a stable dose)
Trial Officials
Imran Aziz, MD
Principal Investigator
Sheffield Teaching Hospitals NHS Foundation Trust
About Sheffield Teaching Hospitals Nhs Foundation Trust
Sheffield Teaching Hospitals NHS Foundation Trust is a leading healthcare institution in the UK, dedicated to delivering high-quality patient care, advancing medical research, and fostering education and training in the health sector. As a prominent sponsor of clinical trials, the Trust collaborates with various stakeholders to facilitate innovative research initiatives that aim to improve treatment outcomes and enhance patient safety. With a commitment to excellence, the organization leverages its extensive clinical expertise and resources to support the development of new therapies and interventions, ultimately contributing to the advancement of healthcare practices both locally and globally.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Sheffield, South Yorkshire, United Kingdom
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials